VISEN Pharmaceuticals Company Profile, Contacts & Intelligence

Pharmaceutical Manufacturing上海, Cn42 employeesASNDFounded 2018
2 contacts with email or phone data2 with email data1 with phone data
Employees
42
Company source estimate
Reachable Contacts
2
Visible contacts with email or phone data
Contacts With Email
2
2 of 4 visible contacts

VISEN Pharmaceuticals Overview

VISEN is an innovative biopharmaceutical company focused on endocrine diseases. We are dedicated to providing innovative therapies and compassionate, patient-centric care, because we believe that achieving better treatment processes and outcomes results in living better lives. Putting patients’ need first, VISEN is committed to providing first-in-class or best-in-class products and treatments for endocrine diseases. Our therapeutic areas cover endocrine diseases in adults and children, and rare endocrine diseases. VISEN comprises seasoned professionals with multinational pharmaceutical experiences and leverages cutting-edge technologies and leading resources across the world. We are focused on the Chinese market, and have established offices in Shanghai, Beijing, Hong Kong and Taipei. We have also launched our Greater China R&D and manufacturing site in Suzhou to enhance R&D, manufacturing and commercialization efforts. Our goal is to enable Chinese endocrine patients to benefit from the world's most advanced and reliable treatment solutions earlier. In 2018, VISEN Pharmaceuticals (VISEN) was formed by Ascendis Pharma A/S (Nasdaq: ASND) and an investor syndicate led by Vivo Capital (along with participation by Sofinnova Ventures), to develop and commercialize Ascendis Pharma’s endocrinology therapies in Greater China, which includes mainland China, Hong Kong, Macau, and Taiwan. In Jan 2021, VISEN had closed a $150 million Series B financing led by Sequoia China with participation from OrbiMed, Sherpa Healthcare Partners, Cormorant, HBM Healthcare Investments, Pivotal bioVenture Partners China, Logos Capital, and CDG Capital, as well as all of the existing investors, including Ascendis Pharma A/S, Vivo Capital and Sofinnova Investments.

Headquarters
上海, Cn
Industry
Pharmaceutical Manufacturing
Founded
2018
Stock Symbol
ASND
NAICS
Pharmaceutical and Medicine Manufacturing, Medicinal and Botanical Manufacturing

VISEN Pharmaceuticals Contact Intelligence

See which contact channels and departments are represented in the visible AeroLeads data.

2 contacts with contact data
2 with email data and 1 with phone data in the visible sample.

VISEN Pharmaceuticals People & Org Chart Preview

Sample people records show job titles and whether email or phone data is available without exposing raw contact details.

VISEN Pharmaceuticals Workforce Composition

Seniority breakdown across 4 visible profiles.

Individual contributor
3
VP / Head
1

Compare Similar Companies to VISEN Pharmaceuticals

Explore companies in related markets and compare their industry and employee estimates.

Company Industry / match Employee estimate Page
Ascendis Pharma Biotechnology Research 1.19K View company
OEP GROUP 友華集團 Pharmaceutical Manufacturing 223 View company
Vivo Capital Investment Management 78 View company
Sironax Biotechnology 44 View company
RareStone Group Pharmaceutical Manufacturing 24 View company
Recbio Biotechnology 20 View company
Wanbang Biopharmaceuticals Co. Ltd Pharmaceutical Manufacturing 12 View company
Innolake Biopharm Pharmaceutical Manufacturing 5 View company
Servier China Pharmaceutical Manufacturing 4 View company
台灣維昇藥業有限公司 VISEN Pharmaceuticals (Taiwan) Ltd. Pharmaceutical Manufacturing 2 View company